Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 15 Biotechnology Angel Investors in China in January 2026

Last updated: Jan 2026 A list of 15 angel investors that invest in Biotechnology startups based in China. We rank investors based on the number of investments they made in Biotechnology companies from China. We update this investor list every month.

Top 15 Biotechnology Angel Investors in China in January 2026

Investor	Biotechnology China investments
Jan Hammer	4
Bingqiang Gao	2
Mr. Xie Youbang	1
Gong Hongjia	1
Suzhou Juming	1
Jiang Guangce	1
Mr. Fang Ying	1
Woyong Fund	1
Mr. Zheng Xiaodong	1
Yi Shuishuishan	1
Jason Zeng	1
Huang Hao	1
Ye Huahua	1
Hua Guoping	1
Yahui Zhou	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Jan Hammer is the partner at Index and the Board observer of Harmonic. Jan attended Oxford University.

Investment focus

Health Care, Medical, Medical Device
Series A, Series B, Seed
China, United States, Czech Republic

Portfolio highlights

Sofía — Improving the way millions of people take care of their health
Transak — Transak offers a simple integration to allow your users to buy more than 100+ cryptocurrencies with credit/debit cards, or bank transfers in more than 120+ countries.
Yuetong Eye Clinic — Yuetong Eye Clinic is a medical institution that provides myopia surgery for adults and myopia prevention and control for adolescents. It is a medical institution focusing on adult myopia surgery and adolescent myopia prevention and control.

Bingqiang Gao is the Independent Non-Executive Director of Q Tech.

Investment focus

Hardware, Robotics, Electronics
Seed, Angel
China, United States

Portfolio highlights

Aiator — Aiator is an artificial intelligence product and technology solutions company focusing on industrial fields and biotechnology. Founded in 2010 by Silicon Valley Artificial Intelligence Scientist in Shenzhen Qianhai DreamWorks, the core members of the team are from the United States, the United Kingdom, Australia and Hong Kong. Currently, there arefour peacock talents and nearly 30 independent intellectual property rights. Weiai Intelligent is committed to carrying out AI empowerment services for enterprises, reducing costs and increasing efficiency.
Shanmu SHANMU — Shanmu SHANMU is a micro medical robot specialist who uses self-developed digital microfluidic chipsets and artificial intelligence algorithms. The robot can continuously check the metabolic components in urine, establishing a link between the user's health status and disease and intelligently establishing multiple disease management cycles.
LuMing Robotics — LuMing Robotics is a developer of intelligent robots. LuMing Robotics focuses on the field of embodied intelligent robots, and its business covers intelligent robot R&D and sales, artificial intelligence algorithm development, etc.

Mr. Xie Youbang founding partner of Jinwell Fund.

Investment focus

Health Care, Biotechnology, Pharmaceutical
Seed
China

Portfolio highlights

Sconray Biotech — Sconray Biotech is a green biotechnology company focusing on synthetic biology and green science. Their products include NAD+, 5-ALA, and diversified ones used in medicine, food, healthcare, daily chemicals, and agriculture.

Gong Hongjia is the the founder of Jiadao Capital.

Investment focus

Audio, Music, Computer
Angel, Seed, Series C
China

Portfolio highlights

KMAX — KMAX specializes in AR and VR content research and development. It has independently developed core technologies such as real-time 3D modeling, 3D generalized cloud connection, cloud VR resource rendering, and an editing engine.
Lead Health — Lead Health is a hard technology startup company that transforms scientific and technological achievements of the academician team. It independently develops life science instruments and biopharmaceutical equipment and has independent intellectual property rights.
CapitalBio Pharma — CapitalBio Pharma is a biotechnology company that specializes in innovative medicines to empower precise diagnosis and treatment. It is a subsidiary of CapitalBio Corporation.

Suzhou Juming

Investment focus

Biotechnology
Series A
China

Portfolio highlights

Zion Pharma — Zion is a leading drug discovery platform that develops "me-better" drugs that address true unmet needs.

Dr. Jiang Guangce is the chairman of Dechuan Medical Fund.

Investment focus

Biopharma, Biotechnology, Pharmaceutical
Seed
China

Portfolio highlights

Renjing Biology — Renjing Biotech is committed to the research and development of innovative drugs based on messenger ribonucleic acid (mRNA).

Mr. Fang Ying, founding partner of Jinwell Fund.

Investment focus

Health Care, Biotechnology, Pharmaceutical
Seed
China

Portfolio highlights

Sconray Biotech — Sconray Biotech is a green biotechnology company focusing on synthetic biology and green science. Their products include NAD+, 5-ALA, and diversified ones used in medicine, food, healthcare, daily chemicals, and agriculture.

Woyong Fund is an individual investor.

Investment focus

Medical, Biotechnology, Pharmaceutical
Seed
China

Portfolio highlights

Boyin Bio — Boyin Bio is an innovative biomaterial research and development and application enterprise.

Mr. Zheng Xiaodong is the Chairman of Tofflon.

Investment focus

Biotechnology, Medical, Hospital
Series A, Series B
China

Portfolio highlights

St Phi Therapeutics — Yizun Biotechnology is a cutting-edge immune cell therapy company that has developed many unique platform technologies, including solid tumor treatment and allogeneic universal cell therapy.
Hengyu Biotechnology — Hengyu Biotechnology is a CXO platform founded by a scientific research team that provides biosafety testing and related process validation.

Yi Shuishuishan

Investment focus

Medical, Biopharma, Health Care
Series A
China

Portfolio highlights

Alioth — Elios focuses on the development and application of technical products for pharmaceutical process technology.

Jason Zeng, one of the Core Founders and Advisor Emeritus of Tencent Group. Jason founded the Group in 1999. As the Chief Operating Officer during 1999 and 2007, Jason was responsible for overseeing the Company's business lines and product portfolios and the managing the Company’s sales and marketing activities across China. Prior toTencent, Jason worked in the Shenzhen Data Telecommunications Bureau and was familiar with the Internet and telecommunications industries in China. Since June 2007, Jason has been the Advisor Emeritus of the Company.

Investment focus

Artificial Intelligence, Machine Learning, Social Media
Seed, Angel, Series B
United States, China

Portfolio highlights

FangDD — FangDD is the an O2O real estate platform in China. It facilitates transactions between property sellers and home buyers through real estate brokers. FangDD works on a "pay-for-performance" business model instead of charging fees for every listings different from other domestic online estate services that charge customers for listingproperty information on the platforms, like SouFun and Anjuke.Currently, FangDD is in cooperation with over 100,000+ brokers, has offices in more than 30 cities and employs around 2500 people."In the first six months of this year(2014), Fangdd’s platform has seen more than 50 billion yuan ($8 billion) worth of real-estate transactions, and is aiming for 150 billion yuan worth of transactions for all of 2014" - Mr. Cao (Lightspeed China Partner).
Hommily — Hommily is a new peer to peer social travel network helping connect travelers to locals from around the globe. Hommily makes it easy to connect with locals for tours, events, drivers, and activities during your trip.
Locale — The Bay Area's best bakeries, restaurants and produce all in one delivery

Huang Hao is the chairman of Yuanxu Fund.

Investment focus

Medical, Biotechnology, Manufacturing
Angel
China

Portfolio highlights

Yiweisen — Yiweisen is a research and development firm that manufactures functional natural compound raw materials.

Ye Huahua is an Angel investor.

Investment focus

Medical, Health Care, Biotechnology
Seed
China

Portfolio highlights

Ruier Weikang — Ruier Weikang focuses on the development and commercialization of brain scientific disease diagnostic, monitoring, and therapy products.

Hua Guoping is the the founder of Hualan Co.

Investment focus

Biotechnology, Manufacturing, Health Diagnostics
Series A
China

Portfolio highlights

Boyi Biotechnology — Boyi Biotechnology is a technology-based firm that provides vital raw materials and complete solutions to biomedical customers in the in vitro diagnostic market. It focus on diagnostic microspheres, testing raw materials, and quality control products.

Zhou Yahui is the founder and Chairman of Kunlun. He previously worked at Thousand Oaks Group as a senior director and vice president. Zhou Yahui attended Tsinghua University.

Investment focus

Software, Health Care, Biotechnology
Series A
China

Portfolio highlights

NeoCura — NeoCura provides an AI platform to collect and analyze molecular biology data and clinical data, enabling physicians to make improve the diagnosis and treatment of cancer patients.

Investors by industry

Community

Artificial intelligence